Nemaura Medical announces public offering

Nemaura Medical (NSDQ:NMRD) announced that it intends to offer shares of its common stock and warrants in an underwritten public offering.

The Loughborough, England-based wearable diagnostic device developer for people with diabetes said in a news release that it also expects to grant a 45-day option to purchase up to an additional 15% of the shares of common stock and/or warrants to purchase common stock, according to a news release.

Nemaura, which is currently commercializing the SugarBeat continuous glucose monitor and the Beat diabetes health subscription service, did not disclose the amount of shares and/or warrants it plans to sell, the offering price of the shares and/or warrants or the overall expected proceeds from the offering.

Last week, Nemaura commissioned the integration of data to its ProBeat app set for U.S. launch this year. SugarBeat had its app launched last month. In April, the company announced that the CGM is set to be repurposed fo…

Read more
  • 0

Nemaura adds activity data to ProBeat app

Nemaura Medical (NSDQ:NMRD) announced today that it commissioned the integration of data to its ProBeat app set for U.S. launch this year.

Data from third-party wearable devices can now be integrated into the ProBeat system, which is a wearable, non-invasive glucose monitor designed to gather big data centered around factors that affect blood glucose levels, according to a news release.

Loughborough, England-based Nemaura Medical said its predictive algorithms and artificial intelligence-based feedback and prompts, combined with the introduction of third-party data, can give users access to information that reveals the relationship between various activities and the factors affecting blood glucose levels.

Nemaura’s SugarBeat, which had its app launched last month, is designed for glucose monitoring on smart devices. In April, the company announced that the CGM is set to be repurposed for continuous temperature monitoring (CTM) to match with the Sug…

Read more
  • 0